Literature DB >> 17336120

Relationship between Helicobacter pylori virulence factors and regulatory cytokines as predictors of clinical outcome.

Carolina Serrano1, Maria Ines Diaz, Alejandra Valdivia, Alex Godoy, Alfredo Peña, Antonio Rollan, Arturo Kirberg, Eduardo Hebel, Jaqueline Fierro, Gabriela Klapp, Alejandro Venegas, Paul R Harris.   

Abstract

Helicobacter pylori infection is highly prevalent in Chile (73%). Usually a minority of infected patients develops complications such as ulcers and gastric cancer that have been associated with the presence of virulence factors (cagA, vacA) and host T helper response (Th1/Th2). Our aim was to evaluate the relationship between strain virulence and host immune response, using a multiple regression approach for the development of a model based on data collected from H. pylori infected patients in Chile. We analyzed levels of selected cytokines determined by ELISA (interleukin (IL)-12, IL-10, interferon (IFN)-gamma and IL-4) and the presence of cagA and vacA alleles polymorphisms determined by PCR in antral biopsies of 41 patients referred to endoscopy. By multiple regression analysis we established a correlation between bacterial and host factors using clinical outcome (gastritis and duodenal ulcer) as dependent variables. The selected model was described by: clinical outcome=0.867491 (cagA)+0.0131847 (IL-12/IL-10)+0.0103503 (IFN-gamma/IL-4) and it was able to explain over 90% of clinical outcomes observations (R(2)=96.4). This model considers that clinical outcomes are better explained by the interaction of host immune factors and strain virulence as a complex and interdependent mechanism.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17336120      PMCID: PMC3821925          DOI: 10.1016/j.micinf.2006.12.012

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  25 in total

1.  Discrimination between cases of duodenal ulcer and gastritis on the basis of putative virulence factors of Helicobacter pylori.

Authors:  Yoshio Yamaoka; Julianne Souchek; Stefan Odenbreit; Rainer Haas; Anna Arnqvist; Thomas Borén; Tadashi Kodama; Michael S Osato; Oscar Gutierrez; Jong G Kim; David Y Graham
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

2.  Helicobacter pylori vacA s1a and s1b alleles from clinical isolates from different regions of Chile show a distinct geographic distribution.

Authors:  M I Diaz; A Valdivia; P Martinez; J L Palacios; P Harris; J Novales; E Garrido; D Valderrama; C Shilling; A Kirberg; E Hebel; J Fierro; R Bravo; F Siegel; G Leon; G Klapp; A Venegas
Journal:  World J Gastroenterol       Date:  2005-10-28       Impact factor: 5.742

Review 3.  Helicobacter pylori and gastrointestinal tract adenocarcinomas.

Authors:  Richard M Peek; Martin J Blaser
Journal:  Nat Rev Cancer       Date:  2002-01       Impact factor: 60.716

4.  Immune response to a 26-kDa protein, alkyl hydroperoxide reductase, in Helicobacter pylori-infected Mongolian gerbil model.

Authors:  J Yan; T Kumagai; M Ohnishi; I Ueno; H Ota
Journal:  Helicobacter       Date:  2001-12       Impact factor: 5.753

5.  Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin.

Authors:  M Gerhard; N Lehn; N Neumayer; T Borén; R Rad; W Schepp; S Miehlke; M Classen; C Prinz
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

Review 6.  Why Helicobacter pylori has Lewis antigens.

Authors:  B J Appelmelk; M A Monteiro; S L Martin; A P Moran; C M Vandenbroucke-Grauls
Journal:  Trends Microbiol       Date:  2000-12       Impact factor: 17.079

7.  Cloning and comparison of ten gene sequences of a Chilean H. pylori strain with other H. pylori strains revealed higher variability for VacA and CagA virulence factors.

Authors:  Ilse Müller; Angelica Medina-Selby; Jose Luis Palacios; Patricio Martinez; Patricio Opazo; Elsa Bruce; Marta Mancilla; Pablo Valenzuela; Arturo Yudelevich; Alejandro Venegas
Journal:  Biol Res       Date:  2002       Impact factor: 5.612

8.  Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA.

Authors:  Manuel R Amieva; Roger Vogelmann; Antonello Covacci; Lucy S Tompkins; W James Nelson; Stanley Falkow
Journal:  Science       Date:  2003-05-30       Impact factor: 47.728

9.  Absence of CD4+CD25+ regulatory T cells is associated with a loss of regulation leading to increased pathology in Helicobacter pylori-infected mice.

Authors:  S Raghavan; M Fredriksson; A-M Svennerholm; J Holmgren; E Suri-Payer
Journal:  Clin Exp Immunol       Date:  2003-06       Impact factor: 4.330

10.  CagA antibodies as a marker of virulence in chilean patients with Helicobacter pylori infection.

Authors:  Paul R Harris; Alex Godoy; Silvana Arenillas; Francisca Riera; Daniela García; Helly Einisman; Alfredo Peña; Antonio Rollán; Ignacio Duarte; Ernesto Guiraldes; Guillermo Perez-Perez
Journal:  J Pediatr Gastroenterol Nutr       Date:  2003-11       Impact factor: 2.839

View more
  8 in total

Review 1.  Macrophage polarization in pathology.

Authors:  Antonio Sica; Marco Erreni; Paola Allavena; Chiara Porta
Journal:  Cell Mol Life Sci       Date:  2015-07-26       Impact factor: 9.261

2.  High Helicobacter pylori Bacterial Load and Low Cytokine Expression Levels Are Associated with Nodular Gastropathy.

Authors:  Rodrigo Mansilla-Vivar; Carolina A Serrano; Camila Palma; Macarena Vera; Caroll Hernandez; Margarita Pizarro; Javiera Torres; Paul R Harris; Eduardo Fuentes-López; Arnoldo Riquelme; Alberto Espino
Journal:  Dig Dis Sci       Date:  2019-08-07       Impact factor: 3.199

3.  Helicobacter pylori HopE and HopV porins present scarce expression among clinical isolates.

Authors:  Maritza Lienlaf; Juan Pablo Morales; María Inés Díaz; Rodrigo Díaz; Elsa Bruce; Freddy Siegel; Gloria León; Paul R Harris; Alejandro Venegas
Journal:  World J Gastroenterol       Date:  2010-01-21       Impact factor: 5.742

4.  Helicobacter pylori: bacterial factors and the role of cytokines in the immune response.

Authors:  Tania Beatriz Romero-Adrián; Jorymar Leal-Montiel; Francisca Monsalve-Castillo; Edgardo Mengual-Moreno; Ernesto García McGregor; Lenis Perini; Ana Antúnez
Journal:  Curr Microbiol       Date:  2009-10-22       Impact factor: 2.188

Review 5.  Systems-wide analyses of mucosal immune responses to Helicobacter pylori at the interface between pathogenicity and symbiosis.

Authors:  Barbara Kronsteiner; Josep Bassaganya-Riera; Casandra Philipson; Monica Viladomiu; Adria Carbo; Vida Abedi; Raquel Hontecillas
Journal:  Gut Microbes       Date:  2016

6.  In situ expression of cagA and risk of gastroduodenal disease in Helicobacter pylori-infected children.

Authors:  James R Rick; Matthew Goldman; Cristina Semino-Mora; Hui Liu; Cara Olsen; Eugenia Rueda-Pedraza; Carolyn Sullivan; Andre Dubois
Journal:  J Pediatr Gastroenterol Nutr       Date:  2010-02       Impact factor: 2.839

Review 7.  Bacterial Involvement in Progression and Metastasis of Adenocarcinoma of the Stomach.

Authors:  Amanda D Morgan; Kevin D Seely; Lauren D Hagenstein; Garrett M Florey; James M Small
Journal:  Cancers (Basel)       Date:  2022-10-06       Impact factor: 6.575

8.  The Exopolysaccharide of Lactobacillus fermentum UCO-979C Is Partially Involved in Its Immunomodulatory Effect and Its Ability to Improve the Resistance against Helicobacter pylori Infection.

Authors:  Valeria Garcia-Castillo; Guillermo Marcial; Leonardo Albarracín; Mikado Tomokiyo; Patricia Clua; Hideki Takahashi; Haruki Kitazawa; Apolinaria Garcia-Cancino; Julio Villena
Journal:  Microorganisms       Date:  2020-03-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.